Researchers Map Genomic Landscape of ALL
Published on
A new study by a multi-institutional group of pediatric cancer researchers, including those at CHOP, has characterized the genomic landscape for acute lymphoblastic leukemia.
Cancer Center News and Updates
31 - 40 of 246
FDA Approves First Potentially Curative Gene Therapy for Beta Thalassemia
Published on
A leading study site for nearly a decade, CHOP will be part of a network of treatment centers in the country offering the therapy to patients who require regular blood transfusions.
CHOP Helps Develop Platform to Speed Up Drug Development for Kids with Cancer
Published on
CHOP has helped launch NCI-backed “Molecular Targets Platform” to streamline and catalyze drug development by harmonizing data about pediatric cancer targets and pathways.
FDA Approves Drug for Rare Cancer
Published on
CHOP played an instrumental role in leading one of two clinical trials that led to the approval of Xalkori® for unresectable, recurrent, or refractory ALK-positive IMT.
CHOP Hosts the Coalition Against Childhood Cancer’s 2022 Summit
Published on
The coalition’s members work to advance a variety of childhood cancer causes by unifying their efforts.
CHOP, a PTEN Foundation Center of Excellence, Hosts PTEN Conference
Published on
As a designated PTEN Center of Excellence, CHOP offers the highest standards in multidisciplinary care.
CHOP Researchers Uncover Molecular Basis of Antigen Processing for Cancer Target MR1
Published on
CHOP researchers have revealed the molecular mechanics of a cell-surface molecule that is a potential immunotherapy target.
First Approved CAR T-Cell Therapy Shows Continued Benefits Five Years Later
Published on
New data on show CAR T-cell therapy leads to durable remission and long-term survival in children and young adults with relapsed or refractory B-ALL.
CHOP Researchers Join Global Team to Take on Solid Tumors in Children
Published on
Four CHOP researchers are part of a world-class research team that will receive $25 million to study solid tumors in children, funded by Cancer Grand Challenges.
New Data Show Benefits of CRISPR-edited Gene Therapy for Blood Disorders in a Larger Patient Group with Longer-Term Follow-Up
Published on
A group of researchers that includes CHOP presented new data on CRISPR-edited gene therapy for blood disorders at an international meeting.